Cargando…
Quantitative Modeling of the High-Throughput Production and In Vivo Kinetics of (Drug-Encapsulating) Liposomes
In developing liposomes for in vivo use, it is important to design the liposomes to have optimal in vivo kinetics, and it is also necessary to identify optimal high-throughput production conditions for these liposomes. Previous work has not definitively established the general relationship between l...
Autor principal: | Wong, Albert |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2859061/ https://www.ncbi.nlm.nih.gov/pubmed/20428243 http://dx.doi.org/10.1371/journal.pone.0010280 |
Ejemplares similares
-
The availability of drug by liposomal drug delivery: Individual kinetics and tissue distribution of encapsulated and released drug in mice after administration of PEGylated liposomal prednisolone phosphate
por: Smits, Evelien A. W., et al.
Publicado: (2018) -
In vivo and in vitro toxicity evaluation of liposome-encapsulated sirolimus
por: Abud, Murilo Batista, et al.
Publicado: (2019) -
Liposomal Encapsulated Rhodomyrtone: A Novel Antiacne Drug
por: Chorachoo, Julalak, et al.
Publicado: (2013) -
In vivo oxalate degradation by liposome encapsulated oxalate oxidase in rat model of hyperoxaluria
por: Dahiya, Tulika, et al.
Publicado: (2013) -
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology
por: Dranchak, Patricia K., et al.
Publicado: (2023)